Essential efficacy and safety profiles of everolimus in Japanese patients with metastatic renal cell carcinoma.

Hirotsugu Uemura,Hiro-omi Kanayama,Norio Nonomura,Tsuneharu Miki,Kenji Nishimura,Akio Matsubara,Yoshihiko Tomita,Masao Kuroda,Yoji Katsuoka,Masato Fujisawa,Shunji Takahashi,Tatsuya Nakatani,Tadashi Matsuda,Isao Hara

Essential efficacy and safety profiles of everolimus in Japanese patients with metastatic renal cell carcinoma.

2011

Hirotsugu Uemura
Hiro-omi Kanayama
Norio Nonomura
Tsuneharu Miki
Kenji Nishimura
Akio Matsubara
Yoshihiko Tomita
Masao Kuroda
Yoji Katsuoka
Masato Fujisawa
Shunji Takahashi
Tatsuya Nakatani
Tadashi Matsuda
Isao Hara

e15140 Background: Although the efficacy of sorafenib and sunitinib was similar in Asian and non-Asian patients with metastatic renal cell carcinoma (mRCC), large differences have been shown in the...

Keywords:

Pathology
Renal cell carcinoma
Internal medicine
Everolimus
Oncology
Cancer research
Medicine
Sorafenib
Sunitinib

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations